{
  "name" : "_cyber.sci-hub.se_MTAuMTAxNi9qLnN0ci4yMDE1LjExLjAxMg==_robb2016.pdf",
  "metadata" : {
    "source" : "META",
    "title" : "The Structure of the Toxin and Type Six Secretion System Substrate Tse2 in Complex with Its Immunity Protein",
    "authors" : [ "Craig S. Robb", "Melissa Robb", "Francis E. Nano", "Alisdair B. Boraston" ],
    "emails" : [ "boraston@uvic.ca", "boraston@uvic.ca" ],
    "sections" : [ {
      "heading" : null,
      "text" : "Short Article"
    }, {
      "heading" : "The Structure of the Toxin",
      "text" : "and Type Six Secretion"
    }, {
      "heading" : "System Substrate Tse2 in Complex with Its Immunity",
      "text" : ""
    }, {
      "heading" : "Protein",
      "text" : ""
    }, {
      "heading" : "Highlights",
      "text" : "d Tse2 from P. aeruginosa has structural features similar to\nADP-ribosylating toxins\nd The active-site of the Tse2 toxin is consistent with an NAD-\ndependent activity\nd Tse2 forms an inactivated heterotetrameric complex with the\nTsi2 anti-toxin\nRobb et al., 2016, Structure 24, 277–284 February 2, 2016 ª2016 Elsevier Ltd All rights reserved http://dx.doi.org/10.1016/j.str.2015.11.012\nAuthors\nCraig S. Robb, Melissa Robb,\nFrancis E. Nano, Alisdair B. Boraston\nCorrespondence boraston@uvic.ca\nIn Brief\nTse2 is a Pseudomonas aeruginosa type\n6 secretion system substrate and\ncytoactive toxin whose structural\nfeatures suggest a relationship with ADP-\nribosylating toxins and an active-site\narrangement consistent with NAD-\ndependent activity, providing the first\ninsight into the molecular basis of Tse2\ntoxicity.\nAccession Numbers\n5AKO"
    }, {
      "heading" : "Structure",
      "text" : ""
    }, {
      "heading" : "Short Article",
      "text" : ""
    }, {
      "heading" : "The Structure of the Toxin and Type Six",
      "text" : ""
    }, {
      "heading" : "Secretion System Substrate Tse2",
      "text" : "in Complex with Its Immunity Protein"
    }, {
      "heading" : "Craig S. Robb,1 Melissa Robb,1 Francis E. Nano,1 and Alisdair B. Boraston1,*",
      "text" : "1Department of Biochemistry and Microbiology, University of Victoria, Victoria, BC V8W 3P6, Canada *Correspondence: boraston@uvic.ca http://dx.doi.org/10.1016/j.str.2015.11.012"
    }, {
      "heading" : "SUMMARY",
      "text" : "Tse2 is a cytoactive toxin secreted by a type six secretion apparatus of Pseudomonas aeruginosa. The Tse2 toxin naturally attacks a target in the cytoplasm of bacterial cells, and can cause toxicity if artificially introduced into eukaryotic cells. The X-ray crystal structure of the complex of Tse2 and its cognate immunity protein Tsi2 revealed a heterotetrameric structure with an extensive binding interface. Structural identity was found between Tse2 and NAD-dependent enzymes, especially ADP-ribosylating toxins, which facilitated the identification of the Tse2 active site and revealed it to be occluded upon binding the inhibitor Tsi2. The structural identity shared with NAD-dependent enzymes, including conserved catalytic residues, suggests that the mechanism of Tse2 toxicity may be NAD dependent."
    }, {
      "heading" : "INTRODUCTION",
      "text" : "Gram-negative bacteria employ type six secretion systems (T6SS) to transfer effector molecules, often toxins, to adjacent bacteria and host cells (Ho et al., 2014). Many of the characterized T6SS toxins target competing bacteria, although there are also examples of eukaryotic targeting (Hood et al., 2010; Jiang et al., 2014). Gene clusters encoding T6SSs are found widely in the genomes of both pathogenic and environmental Gramnegative bacteria (Boyer et al., 2009). Secretion systems that are involved in targeting bacteria are primarily involved in maintaining competitive fitness in polymicrobial communities, but may also function as signaling systems (Russell et al., 2014).\nThe T6SS is analogous to a contractile phage-tail complex that is attached to the bacterial inner membrane and injects effectors into adjacent cells (Basler and Mekalanos, 2012; Leiman et al., 2009). Secretion is thought to be driven by a two-component contractile tube of TssB and TssC that provides energy to force the needle tip, needle body, and associated effectors through the membrane complex of the donor cell and into the target cell (Basler et al., 2012; Clemens et al., 2015). Secretion of an effector molecule is dependent on an interaction with either the\nStructure 24, 27\nputative needle tip complex made of VgrG and PAAR-repeat proteins or the ring-shaped needle body protein Hcp (Shneider et al., 2013; Silverman et al., 2013).\nPseudomonas aeruginosa, an opportunistic pathogen, is a model organism for the study of the T6SS and its effectors. The first three discovered secreted substrates from the H1T6SS from P. aeruginosa are translocated into competing bacterial cells, resulting in death of the recipients (Hood et al., 2010; Russell et al., 2011). Each of these toxins has an associated immunity protein, termed type six immunity (referred to as Tsi 1 through 3), which protects P. aeruginosa from self-intoxication or sister cell intoxication (Russell et al., 2011, 2014). Type six effectors Tse 1 and 3 are hydrolases that degrade the peptidoglycan layer of neighboring bacteria (Russell et al., 2011). Ectopically expressed Tse2 has been shown to be toxic to yeast and mammalian cells, but the toxic effect of Tse2 directly from P. aeruginosa has only been observed against other bacteria (Hood et al., 2010). The toxic activity of Tse2 is directed toward the cytoplasmic compartment of targeted bacterial cells (Li et al., 2012), indicating that the toxin has to cross the two membranes of both the attacking and targeted cell.\nTse2 shares no sequence identity with any protein of known function and, although the structure of its immunity protein is known, the structure and molecular mechanism of Tsi2 inhibition of Tse2 are unknown. Here, the X-ray crystal structure of the complex of Tse2 and Tsi2 reveals the molecular mechanism of inhibition. The structure of Tse2 also led to the discovery of unique structural features that differentiate this cytoactive toxin from the other structurally characterized toxins that are active in the periplasm. Structural identity with bacterial ADP-ribosyltransferase toxins, which informed structureguided mutagenesis, provided critical insight into the active site of Tse2."
    }, {
      "heading" : "RESULTS",
      "text" : ""
    }, {
      "heading" : "Structure of the Tse2/Tsi2 Complex",
      "text" : "Co-expression of the P. aeruginosa tse2 and tsi2 genes in Escherichia coli allowed the production and purification of the protein complex, the structure of which was determined to a resolution of 2.4 Å by molecular replacement using the structure of Tsi2 as a search model (Table 1). The asymmetric unit contained a single heterotetramer comprising two molecules each of Tse2 and Tsi2 (Figure 1A). At the core of the tetramer is a dimer of Tsi2 (Figure 1A), with the two identical\n7–284, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 277\nTable 1. Data Collection and Structural Refinement Statistics\nPaTse2Tsi2\nData Collection\nBeamline SSRL 12-2\nWavelength (Å) 1.000\nTemperature (K) 100 Resolution (Å)a 38.34–2.40 (2.53–2.40)\nSpace group P212121\nUnit cell dimensions\na, b, c (Å) 37.72, 103.14, 114.64\nRmerge 0.089 (0.732)\nI/sI 13.4 (2.3)\nCompleteness (%) 97.6 (99.1)\nRedundancy 4.0 (4.2)\nRefinement\nResolution (Å) 35.83–2.40\nNo. of reflections 16,778\nModel contents A: Tsi2 (2–75)\nB: Tsi2 (1–75) C: Tse2 (3–158, D38–40) D: Tse2 (3–158, D38–40)\nRwork/Rfree 0.20/0.25\nNo. of atoms\nProtein 3,437\nWater 74\nB factors\nOverall 41.9\nProtein 43.5\nWater 37.6\nRmsd\nBond lengths (Å) 0.015\nBond angles ( ) 1.568\nRamachandran plot (%)\nMost favored 97\nOutliers 0.93\nPDB accession code 5AKO aValues in parentheses correspond to the highest-resolution shell (2.53– 2.40 Å).\nsurfaces on either side of the Tsi2 dimer forming binding sites for Tse2 monomers, resulting in a heterotetrameric complex having C2 symmetry. Comparison of the Tsi2 dimer in the complex with existing structures of Tsi2 (PDB: 3STQ, 3RQ9, and 3VPV) gives a root-mean-square deviation (rmsd) of 0.98– 1.27 Å (Li et al., 2012; Zou et al., 2012), implying that Tsi2 does not undergo any significant conformational changes upon binding to Tse2.\nThe symmetry and compact nature of the heterotetrameric complex making up the contents of the asymmetric unit suggests that this is a natural and stable multimer. To provide additional support for this, we performed a more detailed analysis of the interfaces making up the complex using PISA (Krissinel and Henrick, 2007). Overall, five interfaces are involved in forming the heterotetramer: one forming the dimer interface for Tsi2 and two\n278 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All r\nidentical sets of two interfaces mediating the interaction of the two Tse2molecules with the Tsi2 dimer. The Tsi2 dimer interface is 818 Å2, which is roughly 15% of the total Tsi2 monomer surface area, and is predicted to have a binding energy of\n19.3 kcal/mol. The interface of the Tsi2 dimer with a Tse2 monomer displays charge complementarity (Figure 1B) and this binding surface, which involves both Tsi2 molecules, can be divided into two regions whereby each monomer of the Tsi2 dimer has an interface with the one Tse2 molecule (Figure 1C). The larger interface, which we refer to as the primary interface, occurs between the b sheet of Tse2 and a helix 2 of Tsi2 (i.e. between chain C of Tse2 and chain B of Tsi2, and between chain D of Tse2 and chain A of Tsi2). This interface comprises 658 Å2 of surface area ( 12% of the total Tse2 surface area) and is predicted to have a binding energy of 11.2 kcal/mol. Consistent with this large predicted binding energy is the formation of five hydrogen bonds as well as salt bridges between three residues on the basic surface of Tse2 (Arg-89, Arg-90, and Arg-119) and three on the acidic surface of Tsi2 (Glu-38, Asp-45, and Asp49) (Figure 1D). Indeed, supporting the importance of the ionic component of this interface, Li et al. mutated Asp-45 and Glu38 in Tsi2, which pair with Arg-119 and Arg-90, respectively, in Tse2, and this abrogated binding of Tsi2 and Tse2 in vitro and eliminated the ability of Tsi2 to detoxify Tse2 in cell-based assays (Li et al., 2012).\nThe secondary interface is formed by the extended loop of Tse2 enveloping the N and C termini of the second Tsi2 molecule in the Tsi2 dimer (i.e. between chain C of Tse2 and chain A of Tsi2, and between chain D of Tse2 and chain B of Tsi2). This interface comprises 616 Å2 of surface area ( 11% of the total Tse2 surface area) with 14 hydrogen bonds, and is predicted to have a binding energy of 8.7 kcal/mol (Figure 1E). Thus, the total interface between a single Tse2 molecule and the Tsi2 dimer is substantial at 1,274 Å2 ( 24% of the total Tse2 surface area is buried at the interface) with a large number of specific intermolecular interactions (i.e. hydrogen bonds and salt bridges), all of which is consistent with the homotetramer observed in the asymmetric unit being an explicit biological assembly. Furthermore, the complete heterotetramer as it occurs in the asymmetric unit is predicted to be very stable with a Gibbs free energy of dissociation of 23 kcal/mol, which again supports a multimeric structure that is specific and not an assembly that is driven by the formation of a crystal lattice."
    }, {
      "heading" : "The Structure of Tse2",
      "text" : "The structure of Tse2 from the complex comprises an anti-parallel five-stranded b sheet with strands in the order of 3-1-2-5-4 that is packed against a single a helix at the C terminus (Figure 2). Significant extended loops project out from the structure and are stabilized by interactions with the immunity protein in the complex structure. In particular, the loop between strands 1 and 2 also includes a pair of 310 helices and accounts for a full third of the polypeptide. This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).\nights reserved\n(A) Cartoon representation of the Tse2/Tsi2 heterotetramer looking down the two-fold axis of symmetry. The dimer of immunity protein molecules (Tsi2, green/cyan) is able to bind two toxin molecules (Tse2, purple). The dimensions of the heterotetramer are indicated. (B) A heterotrimer portion of the Tse2/Tsi2 complex (top; Tse2, purple; Tsi2, green and cyan) with the interface of this dimer opened along the vertical plane (shown by the dashed line) to expose the interacting surfaces of Tsi2 and Tse2 (bottom left and right, respectively). The surfaces are colored by electrostatic potential. (C) The hydrogen bonding network of the two interfaces highlighting the contributing residues. (D) Details of the primary interface with coloring as in (A). (E) Details of the secondary interface with coloring as in (A).\nWe compared the structure of Tse2 with existing structures in the databases by a Dali structure similarity search (Holm and Sander, 1998). The structures returned as most similar were nicotinamide adenine dinucleotide (NAD)-dependent enzymes from bacteria, notably the mono-ADP-ribosyltransferase toxins (ADPRTs). Themost similar protein structure foundwas the diphtheria toxin (PDB: 1SGK) with a Z score of 4.3, an rmsd of 3.8 Å over 91matchedCa atoms, and 10%amino acid sequence identity (Bell and Eisenberg, 1997). The structural identity between the diphtheria toxin (535 amino acids) and Tse2 (155 amino acids) was primarily limited to the five-stranded b sheet at the core of both folds (see below). The lack of greater structural identity with other available structures indicates that the remaining arrangement of loops and the a helix in Tse2 creates an overall fold that is presently unique to the structural family of toxins to which Tse2 belongs.\nADPRTs, which transfer ADP-ribose to target molecules thereby inactivating them, are most commonly divided into two groups based on different subsets of catalytic residues: the cholera toxin and the diphtheria toxin groups (Holbourn et al., 2006). The cholera toxin group has the consensus sequence\nStructure 24, 277–284, February 2, 2016\nArg, Ser-Thr-Ser, and Glu-X-Glu while the diphtheria toxin group has consensus His, Tyr-X10-Tyr, and Glu. The diphtheria toxin itself was the most similar protein structure to Tse2 while the most structurally similar ADPRT from the cholera toxin group was HopU (PDB: 3UOJ), a T3SS effector from Pseudomonas syringae (Z score 2.7, rmsd of 3.5 Å over 69 matched Ca atoms, and 14% amino acid sequence identity) (Jeong et al., 2011). The structural motif shared between Tse2 and ADP-ribosyltransferases is the characteristic b sheet of this family of toxins (Figure 3A). This structural element houses the catalytic machinery of these toxins while the regions sur-\nrounding this structural core differ between the toxins, contributing to wide sequence variation among ADPRTs (Fieldhouse and Merrill, 2008). In addition to sharing the b sheet, three putative catalytic residues were also structurally conserved between the cholera toxin group of ADPRTs and Tse2 (Figures 3A and 3B). The residues Arg-14 and Ser-80 from Tse2 are structurally equivalent to Arg-128 and Ser-174 from C3 from Clostridium botulinum. However, one catalytic residue shared between the two main groups of ADPRTs is a glutamate (Glu-214 in C3) that in Tse2 is replaced in the structure by His-122 (Figure 3C). The protein ranked second most similar to Tse2 was an NAD-dependent tRNA phosphotransferase (Z score 3.6, rmsd of 3.4 Å for 73 matched Ca atoms, and 12% amino acid sequence identity) (Kato-Murayama et al., 2005). The reaction catalyzed by this enzyme results in the overall transfer of phosphate from the nascent tRNA to ADP-ribose with loss of the nicotinamide group from NAD. This family of proteins is involved in the last step of tRNA maturation and is thought to bind NAD in a manner analogous to the diphtheria toxin. An alignment of Tse2, the two groups of ADPRTs, and the tRNA phosphotransferase reveals partial active-site conservation between the\nª2016 Elsevier Ltd All rights reserved 279\nFigure 2. The Structure of Tse2 from the Complex\nThe structure is shown as a cartoon colored blue to red from the N terminus to the C terminus. The secondary structure elements of Tse2 are labeled sequentially by type. The dimensions of the Tse2 monomer are indicated.\nphosphotransferase, ADPRTs, and Tse2 (Figure 3C). In the tRNA phosphotransferase the conserved ADPRT glutamate is replaced with a valine, whereas in Tse2 this position is occupied by a histidine."
    }, {
      "heading" : "Identification of a Putative Active Site",
      "text" : "Our structural comparisons of Tse2 with NAD-dependent proteins predict that the set of residues in Tse2 (Arg-14, Ser-80, His-122) that are structurally conserved with the catalytic residues in the NAD-dependent enzymes have a role in the toxicity of Tse2. To test this hypothesis, we performed structure-guided mutagenesis to generate alanine substitution mutations for Arg14, Ser-80, and His-122. Due to its proximity to His-122, we also mutated Asp-112 (Figure 3A). We compared the growth of E. coli expressing the wild-type and mutant Tse2 genes, which were under isopropyl b-D-1-thiogalactopyranoside (IPTG)-inducible T7 RNA polymerase control, in the presence or absence of the inducer. E. coli expressing wild-type Tse2 was unable to grow in the presence of IPTG, but in the absence of IPTG grew the same as the control culture expressing Tsi2, which had the same growth properties with andwithout the inducer (Figure 3D). The growth of the strains expressing Tse2 with the mutations R14A, S80A, and H122A were the same as the uninduced wild-type and Tsi2 cultures, regardless of whether IPTG was added to cultures or not. Under the conditions to induce expression of the D112A mutant protein we observed a reduction of growth, but not as profound a reduction as when native Tse2 is expressed (Figure 3D). To demonstrate the level of expression of the Tse2 mutated proteins, we performed western blotting. The three Tse2 variants that showed a reversal of the growth defect were produced in a soluble form indicating that they are non-toxic, whereas Tse2 and Tse2 D112A were not detectable, consistent with the nearly complete lack of growth of these strains (Figure 3E)."
    }, {
      "heading" : "DISCUSSION",
      "text" : "Determination of the Tse2/Tsi2 complex structure showed Tse2 to possess a b-sheet platform that is structurally conserved with ADPRTs and tRNA phosphotransferases. Notably, this structural\n280 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All rights reserved\nfeature also acts as the support for the catalytic centers of these NAD-dependent enzymes, which is largely also conserved in Tse2. The abrogation of toxicity for the R14A, S80A, and H122A mutant Tse2 proteins indicates the importance of these amino acids in the mechanism of Tse2 toxicity and, given their conservation with NAD-reactive enzymes, also supports their assignment\nas being involved in a catalytic reaction the we propose involves NAD. Asp-112 lies beside the putative catalytic His-122 and could contribute to catalysis, but appears to be dispensable for full toxicity of Tse2. Notably, when the amino acid sequence conservation among Tse2 homologs is mapped onto the surface of the Tse2 structure, the region containing the these functionally important putative catalytic residues and, indeed, many of the residues around the putative catalytic center are highly conserved (Figure 3F). That these residues are conserved throughout the Tse2 family points to the general importance of these amino acids and likely common function for these family members.\nThe deployment of such a highly toxic molecule requires that the bacterium protect itself from Tse2, which P. aeruginosa does using the Tsi2 anti-toxin. The large buried surface area of the Tse2/Tsi2 complex suggests a tight interaction between the two components when forming the inhibited heterotetramer. Notably, the cleft housing the putative catalytic residues of Tse2 sits directly between the primary and secondary Tse2/Tsi2 binding interfaces and is completely occluded upon binding the formation of the complex, providing a simple molecular-level explanation for the efficient means of Tsi2 inhibiting the effects of Tse2 on the donor cell. Unlike the residues at the putative catalytic center, the majority of surface-exposed amino acids on Tse2 that are involved in binding Tsi2 shows are not conserved among the Tse2 family (compare Figures 3F and 3G). This implies that the recognition of the toxin by anti-toxin is species dependent, in keeping with the concept that this is a specific form of self-recognition to prevent self-intoxication.\nThe secreted chaperone Hcp is needed for the intracellular stability of Tse2 in P. aeruginosa, and evidence indicates that it is likely bound to the interior of the Hcp ring (Silverman et al., 2013). The Tse2/Tsi2 heterotetramer is a lozenge shape that is\n93 Å long and 41 Å in diameter (Figure 1A) and thus may thread lengthwise into the 46-Å diameter central cavity of the Hcp hexameric ring. However, this possible mode of chaperoning the inactive Tse2/Tsi2 heterotetramer necessitates that there be a mechanism for the segregation of Tse2 and Tsi2 during the secretion process so that active Tse2may be delivered to the recipient cell. This is formally possible, but we find it unlikely\nStructure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All rights reserved 281\ngiven the large amounts of energy that would likely be required to dissociate the Tse2/Tsi2 heterotetramer. The heterotetrameric arrangement of the Tse2/Tsi2 toxin-anti-toxin complex is reminiscent of the quaternary structure formed by two other T6SS toxin-anti-toxin pairs (Yang et al., 2014; Zhang et al., 2013). In these cases, the high affinity of complex formation represented a dead end for the toxins. Thus, we favor the concept that that the inhibited form of Tse2 found in the crystal structure represents a secretion-incompetent form and that Hcp is responsible for chaperoning the Tse2 monomer. The length and diameter of the folded Tse2 monomer are 52 Å and 41 Å (Figure 2), respectively, and therefore of appropriate size to essentially fill the center of the Hcp ring, as was observed in electron microscopy studies by Silverman et al. (2013). The structural features of Tse2 are consistent with a mechanism of toxicity that is NAD dependent and may provide ADP-ribosyltransferase activity, although this remains to be conclusively determined. This potential activity, which parallels the cytotoxin effectors of the type III secretion system (Deng and Barbieri, 2008), distinguishes Tse2 from other T6SS effectors and, with an appropriately conserved targetmolecule, would explain the ability of Tse2 to act as a cytotoxin toward both prokaryotic and eukaryotic cells."
    }, {
      "heading" : "EXPERIMENTAL PROCEDURES",
      "text" : ""
    }, {
      "heading" : "Cloning, Production, Purification, Crystallization, and Structure Solving",
      "text" : "The genes for Tse2 and Tsi2 (PA2702, PA2703) were cloned into pET28 by amplifying the complete open reading frame of each gene (encoding residues 1–158 and 1–77) using genomic P. aeruginosa PAO1 DNA (ATCC 47085D-5) and appropriate primers (Table S1). These amplicons were digested with appropriate restriction enzymes and ligated into pET-28 or pET-22b making pET28-Tse2, pET22-Tse2, and pET28-Tsi2. For co-expression, Tse2 was reamplified from pET28-Tse2 including the N-terminal His-tag and thrombin cleavage site, digested, and ligated into the NcoI-NotI site of pETDUET. This vector was re-digested and Tsi2 was ligated into the second multiple cloning site at the NdeI-XhoI site to generate the complete vector pETDUET-Tse2Tsi2. BL21 (DE3) harboring respective vectors were grown in LB medium supplemented with kanamycin or ampicillin. The cultures were grown at 37 C for 6 hr and induced at 16 C for 16 hr with 0.5 mM IPTG, cells harvested by centrifugation, and chemically lysed (Robb et al., 2012). Protein was purified from clarified by immobilized metal affinity chromatography, exchanged by dialysis into 20 mM Tris (pH 8.0) and 150 mM NaCl, and concentrated to 10 mg/ml for crystallization. Crystals were obtained by the hanging-drop vapor diffusion method in 20 mM Tris (pH 8.5), 0.2 M NaCl, and 22% polyethylene glycol 4000. Crystals were cryo-protected in crystallization solution supplemented with 25% ethylene glycol and placed directly in a cryo stream at 113 K. A diffraction dataset was collected at a wavelength of 1 Å. Data processing was carried out in XDS and SCALA from the CCP4 package in the space group P212121. The structure was solved by molecular replacement searching for two Tsi2 monomers (PDB: 3VPV) using Phaser-MR. Autobuilding was carried\nHighlighted in purple, the diphtheria toxin, exotoxin A from Pseudomonas aeru comparison (Bennett and Eisenberg, 1994; Kato-Murayama et al., 2005; Wedekin the alignment. The residues that line the putative catalytic site of Tse2 that were known to be catalytic residues in the ADP-ribosylating toxins. (D) Growth curves of E. coli harboring plasmids that carry Tse2, Tse2 mutants, or T in red for each strain. The dashed lines show the SD of triplicate measurements. (E) A western blot probing for histidine-tagged Tse2 from E. coli samples from th (F) Sequence conservation mapped onto the structure of Tse2. The colors of th mutated residues from the toxicity experiments are highlighted. Sequence alignm (G) The structure of Tse2 with the surfaces forming the binding interface with Tsi2 See also Figure S1.\n282 Structure 24, 277–284, February 2, 2016 ª2016 Elsevier Ltd All r\nout in Phenix and resulted in a nearly complete model (Adams et al., 2010). Rounds of restrained refinement in Refmac and manual building in Coot were used to complete the model (Emsley et al., 2010; Murshudov et al., 2011). Structure validation was carried out using MolProbity, and Ramachandran statistics were taken from this analysis (Chen et al., 2010). The coordinates and structure factors have been deposited in the PDB (PDB: 5AKO)."
    }, {
      "heading" : "Mutagenesis and Toxicity Experiments",
      "text" : "Mutagenesis of the putative active site was performed as previously described (Liu and Naismith, 2008). In brief, partially overlapping oligonucleotides were used to amplify by PCR the entire pET28-Tse2 plasmid, which was then transformed into competent E. coli DH5a (Table S1). The point mutations were confirmed by sequencing.\nE. coli BL21 (DE3) pLysS cells were transformed with either pET28-Tse2, mutants of pET28-Tse2, or pET28-Tsi2. Starter cultures were grown for 6 hr in LB medium at 37 C with shaking before being diluted 25 times in 250 ml of medium in triplicate in a 96-well tray. The trays were incubated 37 C with periodic shaking in the plate reader (5 s every 15 min). Measurements of absorbance at 595 nm were collected every 15 min for 8 hr. Growth was measured for each strain with or without 1 mM IPTG. Cells were resuspended in Laemmli buffer and heated to 90 C for 30min. Samples were centrifuged and separated by SDS-PAGE on a 15% polyacrylamide gel. Following electrophoresis, the samples were transferred to nitrocellulose at 30 V for 1 hr. The nitrocellulose membrane was blocked using 5% milk in PBS with 1% Tween 20 (PBS-T) overnight at 16 C. The blocked membrane was probed with rabbit polyclonal immunoglobulin G against polyhistidine (Santa Cruz Biotechnology) in PBS-T with 1% milk for 1 hr at room temperature. After washing, a goat anti-rabbit monoclonal with a fluorescent dye was applied in PBS-T with 1% milk for 1 hr at room temperature. The membrane was scanned at 700 and 800 nm to measure the fluorescence."
    }, {
      "heading" : "ACCESSION NUMBERS",
      "text" : "The coordinates and structure factors of the complex of Tse2 and Tsi2 from Pseudomonas aeruginosa reported in this paper have been deposited in the PDB (PDB: 5AKO).\nSUPPLEMENTAL INFORMATION\nSupplemental Information includes one figure and one table and can be found with this article online at http://dx.doi.org/10.1016/j.str.2015.11.012."
    }, {
      "heading" : "AUTHOR CONTRIBUTIONS",
      "text" : "Conceptualization: C.S.R. and A.B.B.; methodology: C.S.R. and A.B.B.; investigation: C.S.R. and M.C.; writing—original draft: C.S.R.; writing—review and editing: C.S.R., F.E.N., and A.B.B.; funding acquisition: A.B.B. and F.E.N.; supervision: A.B.B. and F.E.N."
    }, {
      "heading" : "ACKNOWLEDGMENTS",
      "text" : "This work was supported by a Canadian Institutes for Health Research (CIHR) Operating Grant (FRN 89812).We thank the beamline staff at the Stanford Synchrotron Research Laboratory BL12-2. A.B.B. thanks a Canada Research\nginosa, and an NAD-dependent tRNA phosphotransferase are included for\nd et al., 2001). The secondary structure assignments from (B) are shown above mutated to alanine are denoted with a star. Residues outlined in red are those\nsi2. The induced cultures are shown in blue compared with uninduced cultures WT, wild-type. e growth curves in (D). e residues are coded depending on conservation of a particular residue. The\nent used for this analysis is presented in Figure S1.\ncolored green and cyan. The orientation of the protein is identical to that in (A).\nights reserved\nChair in Molecular Interactions, an MSFHR Scholar Award, and an EWR Steacie Memorial Fellowship for support.\nReceived: August 31, 2015 Revised: November 4, 2015 Accepted: November 23, 2015 Published: December 31, 2015"
    } ],
    "references" : [ {
      "title" : "PHENIX: a comprehensive Python-based system for macromolecular structure solution",
      "author" : [ "P.D. Adams", "P.V. Afonine", "G. Bunkóczi", "V.B. Chen", "I.W. Davis", "N. Echols", "J.J. Headd", "Hung", "L.-W", "G.J. Kapral", "Grosse-Kunstleve", "R.W" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Adams et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Adams et al\\.",
      "year" : 2010
    }, {
      "title" : "Type 6 secretion dynamics within and between bacterial cells",
      "author" : [ "M. Basler", "J.J. Mekalanos" ],
      "venue" : "Science",
      "citeRegEx" : "Basler and Mekalanos,? \\Q2012\\E",
      "shortCiteRegEx" : "Basler and Mekalanos",
      "year" : 2012
    }, {
      "title" : "Type VI secretion requires a dynamic contractile phage",
      "author" : [ "M. Basler", "M. Pilhofer", "G.P. Henderson", "G.J. Jensen", "J.J. Mekalanos" ],
      "venue" : "tail-like structure",
      "citeRegEx" : "Basler et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Basler et al\\.",
      "year" : 2012
    }, {
      "title" : "Crystal structure of nucleotide-free diphtheria toxin",
      "author" : [ "C.E. Bell", "D. Eisenberg" ],
      "venue" : "Biochemistry",
      "citeRegEx" : "Bell and Eisenberg,? \\Q1997\\E",
      "shortCiteRegEx" : "Bell and Eisenberg",
      "year" : 1997
    }, {
      "title" : "Refined structure of monomeric diphtheria toxin at 2.3 A resolution",
      "author" : [ "M.J. Bennett", "D. Eisenberg" ],
      "venue" : "Protein Sci",
      "citeRegEx" : "Bennett and Eisenberg,? \\Q1994\\E",
      "shortCiteRegEx" : "Bennett and Eisenberg",
      "year" : 1994
    }, {
      "title" : "Structural insights into the effector-immunity system Tse1/Tsi1 from Pseudomonas aeruginosa",
      "author" : [ "J. Benz", "C. Sendlmeier", "T.R.M. Barends", "A. Meinhart" ],
      "venue" : "PLoS One",
      "citeRegEx" : "Benz et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Benz et al\\.",
      "year" : 2012
    }, {
      "title" : "Dissecting the bacterial type VI secretion system by a genome wide in silico analysis: what can be learned from available microbial genomic resources",
      "author" : [ "F. Boyer", "G. Fichant", "J. Berthod", "Y. Vandenbrouck", "I. Attree" ],
      "venue" : "BMC Genomics",
      "citeRegEx" : "Boyer et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Boyer et al\\.",
      "year" : 2009
    }, {
      "title" : "MolProbity: all-atom structure validation for macromolecular crystallography",
      "author" : [ "V.B. Chen", "W.B. Arendall", "3rd", "J.J. Headd", "D.A. Keedy", "R.M. Immormino", "G.J. Kapral", "L.W. Murray", "J.S. Richardson", "D.C. Richardson" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Chen et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Chen et al\\.",
      "year" : 2010
    }, {
      "title" : "Atomic structure of T6SS reveals interlaced array essential to function",
      "author" : [ "D.L. Clemens", "P. Ge", "Lee", "B.-Y", "M.A. Horwitz", "Z.H. Zhou" ],
      "venue" : "Cell 160,",
      "citeRegEx" : "Clemens et al\\.,? \\Q2015\\E",
      "shortCiteRegEx" : "Clemens et al\\.",
      "year" : 2015
    }, {
      "title" : "Molecular mechanisms of the cytotoxicity of ADP-ribosylating toxins",
      "author" : [ "Q. Deng", "J.T. Barbieri" ],
      "venue" : "Annu. Rev. Microbiol",
      "citeRegEx" : "Deng and Barbieri,? \\Q2008\\E",
      "shortCiteRegEx" : "Deng and Barbieri",
      "year" : 2008
    }, {
      "title" : "Structural insights into the inhibition of type VI effector Tae3 by its immunity protein Tai3",
      "author" : [ "C. Dong", "H. Zhang", "Gao", "Z.-Q", "Wang", "W.-J", "Z. She", "Liu", "G.-F", "Shen", "Y.-Q", "Su", "X.-D", "Dong", "Y.-H" ],
      "venue" : "Biochem. J. 454,",
      "citeRegEx" : "Dong et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Dong et al\\.",
      "year" : 2013
    }, {
      "title" : "Features and development of Coot",
      "author" : [ "P. Emsley", "B. Lohkamp", "W.G. Scott", "K. Cowtan" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Emsley et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Emsley et al\\.",
      "year" : 2010
    }, {
      "title" : "Needle in the haystack: structurebased toxin discovery",
      "author" : [ "R.J. Fieldhouse", "A.R. Merrill" ],
      "venue" : "Trends Biochem. Sci",
      "citeRegEx" : "Fieldhouse and Merrill,? \\Q2008\\E",
      "shortCiteRegEx" : "Fieldhouse and Merrill",
      "year" : 2008
    }, {
      "title" : "Crystal structure of the pertussis toxin-ATP complex: a molecular sensor",
      "author" : [ "B. Hazes", "A. Boodhoo", "S.A. Cockle", "R.J. Read" ],
      "venue" : "J. Mol. Biol",
      "citeRegEx" : "Hazes et al\\.,? \\Q1996\\E",
      "shortCiteRegEx" : "Hazes et al\\.",
      "year" : 1996
    }, {
      "title" : "A view to a kill: the bacterial type VI secretion system",
      "author" : [ "B.T. Ho", "T.G. Dong", "J.J. Mekalanos" ],
      "venue" : "Cell Host Microbe",
      "citeRegEx" : "Ho et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Ho et al\\.",
      "year" : 2014
    }, {
      "title" : "A family of killer toxins",
      "author" : [ "K.P. Holbourn", "C.C. Shone", "K.R. Acharya" ],
      "venue" : "FEBS J",
      "citeRegEx" : "Holbourn et al\\.,? \\Q2006\\E",
      "shortCiteRegEx" : "Holbourn et al\\.",
      "year" : 2006
    }, {
      "title" : "Touring protein fold space with Dali/FSSP",
      "author" : [ "L. Holm", "C. Sander" ],
      "venue" : "Nucleic Acids Res",
      "citeRegEx" : "Holm and Sander,? \\Q1998\\E",
      "shortCiteRegEx" : "Holm and Sander",
      "year" : 1998
    }, {
      "title" : "A type VI secretion system of Pseudomonas aeruginosa targets a toxin to bacteria",
      "author" : [ "R.D. Hood", "P. Singh", "F. Hsu", "T. Güvener", "M.A. Carl", "R.R.S. Trinidad", "J.M. Silverman", "B.B. Ohlson", "K.G. Hicks", "Plemel", "R.L" ],
      "venue" : "Cell Host Microbe",
      "citeRegEx" : "Hood et al\\.,? \\Q2010\\E",
      "shortCiteRegEx" : "Hood et al\\.",
      "year" : 2010
    }, {
      "title" : "Structure function analysis of an ADP-ribosyltransferase type III effector and its RNA-binding target in plant immunity",
      "author" : [ "B. Jeong", "Y. Lin", "A. Joe", "M. Guo", "C. Korneli", "H. Yang", "P. Wang", "M. Yu", "R.L. Cerny", "D Staiger" ],
      "venue" : "J. Biol",
      "citeRegEx" : "Jeong et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Jeong et al\\.",
      "year" : 2011
    }, {
      "title" : "J.,Yang,G., andJin,Q. (2014).APseudomonas aeruginosa type VI secretion phospholipase D effector targets both prokaryotic and eukaryotic cells",
      "author" : [ "F. Jiang", "N.R. Waterfield", "Yang" ],
      "venue" : "Cell Host Microbe 15,",
      "citeRegEx" : "Jiang et al\\.,? \\Q2005\\E",
      "shortCiteRegEx" : "Jiang et al\\.",
      "year" : 2005
    }, {
      "title" : "Inference of macromolecular assemblies from crystalline state",
      "author" : [ "E. Krissinel", "K. Henrick" ],
      "venue" : "J. Mol. Biol",
      "citeRegEx" : "Krissinel and Henrick,? \\Q2007\\E",
      "shortCiteRegEx" : "Krissinel and Henrick",
      "year" : 2007
    }, {
      "title" : "Type VI secretion apparatus and phage tail-associated protein complexes share a common evolutionary origin",
      "author" : [ "P.G. Leiman", "M. Basler", "U.A. Ramagopal", "J.B. Bonanno", "J.M. Sauder", "S. Pukatzki", "S.K. Burley", "S.C. Almo", "J.J. Mekalanos" ],
      "venue" : "Proc. Natl. Acad. Sci. USA",
      "citeRegEx" : "Leiman et al\\.,? \\Q2009\\E",
      "shortCiteRegEx" : "Leiman et al\\.",
      "year" : 2009
    }, {
      "title" : "Structural basis for type VI secretion effector recognition by a cognate immunity protein",
      "author" : [ "M. Li", "I. Le Trong", "M.A. Carl", "E.T. Larson", "S. Chou", "J.A. De Leon", "S.L. Dove", "R.E. Stenkamp", "J.D. Mougous" ],
      "venue" : "PLoS Pathog",
      "citeRegEx" : "Li et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Li et al\\.",
      "year" : 2012
    }, {
      "title" : "An efficient one-step site-directed deletion, insertion, single and multiple-site plasmid mutagenesis protocol",
      "author" : [ "H. Liu", "J.H. Naismith" ],
      "venue" : "BMC Biotechnol",
      "citeRegEx" : "Liu and Naismith,? \\Q2008\\E",
      "shortCiteRegEx" : "Liu and Naismith",
      "year" : 2008
    }, {
      "title" : "NAD binding induces conformational changes in Rho ADP-ribosylating clostridium botulinum C3 exoenzyme",
      "author" : [ "J. Ménétrey", "G. Flatau", "E.A. Stura", "Charbonnier", "J.-B", "F. Gas", "Teulon", "J.-M", "Le Du", "M.-H", "P. Boquet", "A. Menez" ],
      "venue" : "J. Biol",
      "citeRegEx" : "Ménétrey et al\\.,? \\Q2002\\E",
      "shortCiteRegEx" : "Ménétrey et al\\.",
      "year" : 2002
    }, {
      "title" : "REFMAC 5 for the refinement of macromolecular crystal structures",
      "author" : [ "G.N. Murshudov", "P. Skubák", "A.A. Lebedev", "N.S. Pannu", "R.A. Steiner", "R.A. Nicholls", "M.D. Winn", "F. Long", "A.A. Vagin" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Murshudov et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Murshudov et al\\.",
      "year" : 2011
    }, {
      "title" : "The structure of the conserved type six secretion protein TssL (DotU) from Francisella novicida",
      "author" : [ "C.S. Robb", "F.E. Nano", "A.B. Boraston" ],
      "venue" : "J. Mol. Biol",
      "citeRegEx" : "Robb et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Robb et al\\.",
      "year" : 2012
    }, {
      "title" : "Type VI secretion delivers bacteriolytic effectors to target cells",
      "author" : [ "A.B. Russell", "R.D. Hood", "N.K. Bui", "M. LeRoux", "W. Vollmer", "J.D. Mougous" ],
      "venue" : "Nature 475,",
      "citeRegEx" : "Russell et al\\.,? \\Q2011\\E",
      "shortCiteRegEx" : "Russell et al\\.",
      "year" : 2011
    }, {
      "title" : "Type VI secretion system effectors: poisons with a purpose",
      "author" : [ "A.B. Russell", "S.B. Peterson", "J.D. Mougous" ],
      "venue" : "Nat. Rev. Microbiol",
      "citeRegEx" : "Russell et al\\.,? \\Q2014\\E",
      "shortCiteRegEx" : "Russell et al\\.",
      "year" : 2014
    }, {
      "title" : "PAAR-repeat proteins sharpen and diversify the type VI secretion system",
      "author" : [ "M.M. Shneider", "S.A. Buth", "B.T. Ho", "M. Basler", "J.J. Mekalanos", "P.G. Leiman" ],
      "venue" : "spike. Nature",
      "citeRegEx" : "Shneider et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Shneider et al\\.",
      "year" : 2013
    }, {
      "title" : "Haemolysin coregulated protein is an exported receptor and chaperone of type VI secretion substrates",
      "author" : [ "J.J.M. Silverman", "D.D.M. Agnello", "H. Zheng", "B.B.T. Andrews", "M. Li", "C.E. Catalano", "T. Gonen", "J.D. Mougous", "E. Carlos" ],
      "venue" : "Mol. Cell",
      "citeRegEx" : "Silverman et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Silverman et al\\.",
      "year" : 2013
    }, {
      "title" : "Structural basis for type VI secreted peptidoglycan DL-endopeptidase function, specificity and neutralization in Serratia marcescens",
      "author" : [ "V. Srikannathasan", "G. English", "N.K. Bui", "K. Trunk", "P.E.F. O’Rourke", "V.A. Rao", "W. Vollmer", "S.J. Coulthurst", "W.N. Hunter" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Srikannathasan et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Srikannathasan et al\\.",
      "year" : 2013
    }, {
      "title" : "Structural basis of actin recognition and arginine ADP-ribosylation by Clostridium perfringens iota-toxin",
      "author" : [ "H. Tsuge", "M. Nagahama", "M. Oda", "S. Iwamoto", "H. Utsunomiya", "V.E. Marquez", "N. Katunuma", "M. Nishizawa", "J. Sakurai" ],
      "venue" : "Proc. Natl. Acad. Sci. USA",
      "citeRegEx" : "Tsuge et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Tsuge et al\\.",
      "year" : 2008
    }, {
      "title" : "Crystal structure of the Clostridium limosum C3 exoenzyme",
      "author" : [ "M. Vogelsgesang", "B. Stieglitz", "C. Herrmann", "A. Pautsch", "K. Aktories" ],
      "venue" : "FEBS Lett",
      "citeRegEx" : "Vogelsgesang et al\\.,? \\Q2008\\E",
      "shortCiteRegEx" : "Vogelsgesang et al\\.",
      "year" : 2008
    }, {
      "title" : "Complex structure of type VI peptidoglycan muramidase effector and a cognate immunity protein",
      "author" : [ "T. Wang", "J. Ding", "Y. Zhang", "Wang", "D.-C", "W. Liu" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Wang et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2013
    }, {
      "title" : "Refined crystallographic structure of Pseudomonas aeruginosa exotoxin A and its implications for the molecular mechanism of toxicity",
      "author" : [ "J.E. Wedekind", "C.B. Trame", "M. Dorywalska", "P. Koehl", "T.M. Raschke", "M. McKee", "D. FitzGerald", "R.J. Collier", "D.B. McKay" ],
      "venue" : "J. Mol. Biol",
      "citeRegEx" : "Wedekind et al\\.,? \\Q2001\\E",
      "shortCiteRegEx" : "Wedekind et al\\.",
      "year" : 2001
    }, {
      "title" : "Identification, structure, and function of a novel type VI secretion peptidoglycan glycoside hydrolase",
      "author" : [ "J.C. Whitney", "S. Chou", "A.B. Russell", "J. Biboy", "T.E. Gardiner", "M.A. Ferrin", "M. Brittnacher", "W. Vollmer", "J.D. Mougous" ],
      "venue" : "effector-immunity pair. J. Biol",
      "citeRegEx" : "Whitney et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Whitney et al\\.",
      "year" : 2013
    }, {
      "title" : "Molecular mechanism for self-protection against the type VI secretion system in Vibrio cholerae",
      "author" : [ "Z. Fan" ],
      "venue" : "Acta Crystallogr. D Biol. Crystallogr",
      "citeRegEx" : "Fan,? \\Q2014\\E",
      "shortCiteRegEx" : "Fan",
      "year" : 2014
    }, {
      "title" : "Structure of the type VI effector-immunity complex (Tae4-Tai4) provides novel insights into the inhibition mechanism of the effector by its immunity protein",
      "author" : [ "H. Zhang", "Gao", "Z.-Q", "Wang", "W.-J", "Liu", "G.-F", "Xu", "J.-H", "Su", "X.-D", "Dong", "Y.-H" ],
      "venue" : "J. Biol. Chem",
      "citeRegEx" : "Zhang et al\\.,? \\Q2013\\E",
      "shortCiteRegEx" : "Zhang et al\\.",
      "year" : 2013
    }, {
      "title" : "Crystal structure of Pseudomonas aeruginosa Tsi2 reveals a stably folded superhelical antitoxin",
      "author" : [ "M. Wang", "S. Cui", "Q. Jin" ],
      "venue" : "J. Mol. Biol",
      "citeRegEx" : "Wang et al\\.,? \\Q2012\\E",
      "shortCiteRegEx" : "Wang et al\\.",
      "year" : 2012
    } ],
    "referenceMentions" : [ {
      "referenceID" : 14,
      "context" : "Gram-negative bacteria employ type six secretion systems (T6SS) to transfer effector molecules, often toxins, to adjacent bacteria and host cells (Ho et al., 2014).",
      "startOffset" : 146,
      "endOffset" : 163
    }, {
      "referenceID" : 17,
      "context" : "Many of the characterized T6SS toxins target competing bacteria, although there are also examples of eukaryotic targeting (Hood et al., 2010; Jiang et al., 2014).",
      "startOffset" : 122,
      "endOffset" : 161
    }, {
      "referenceID" : 6,
      "context" : "Gene clusters encoding T6SSs are found widely in the genomes of both pathogenic and environmental Gramnegative bacteria (Boyer et al., 2009).",
      "startOffset" : 120,
      "endOffset" : 140
    }, {
      "referenceID" : 28,
      "context" : "Secretion systems that are involved in targeting bacteria are primarily involved in maintaining competitive fitness in polymicrobial communities, but may also function as signaling systems (Russell et al., 2014).",
      "startOffset" : 189,
      "endOffset" : 211
    }, {
      "referenceID" : 1,
      "context" : "The T6SS is analogous to a contractile phage-tail complex that is attached to the bacterial inner membrane and injects effectors into adjacent cells (Basler and Mekalanos, 2012; Leiman et al., 2009).",
      "startOffset" : 149,
      "endOffset" : 198
    }, {
      "referenceID" : 21,
      "context" : "The T6SS is analogous to a contractile phage-tail complex that is attached to the bacterial inner membrane and injects effectors into adjacent cells (Basler and Mekalanos, 2012; Leiman et al., 2009).",
      "startOffset" : 149,
      "endOffset" : 198
    }, {
      "referenceID" : 2,
      "context" : "Secretion is thought to be driven by a two-component contractile tube of TssB and TssC that provides energy to force the needle tip, needle body, and associated effectors through the membrane complex of the donor cell and into the target cell (Basler et al., 2012; Clemens et al., 2015).",
      "startOffset" : 243,
      "endOffset" : 286
    }, {
      "referenceID" : 8,
      "context" : "Secretion is thought to be driven by a two-component contractile tube of TssB and TssC that provides energy to force the needle tip, needle body, and associated effectors through the membrane complex of the donor cell and into the target cell (Basler et al., 2012; Clemens et al., 2015).",
      "startOffset" : 243,
      "endOffset" : 286
    }, {
      "referenceID" : 29,
      "context" : "Structure 24, 27 putative needle tip complex made of VgrG and PAAR-repeat proteins or the ring-shaped needle body protein Hcp (Shneider et al., 2013; Silverman et al., 2013).",
      "startOffset" : 126,
      "endOffset" : 173
    }, {
      "referenceID" : 30,
      "context" : "Structure 24, 27 putative needle tip complex made of VgrG and PAAR-repeat proteins or the ring-shaped needle body protein Hcp (Shneider et al., 2013; Silverman et al., 2013).",
      "startOffset" : 126,
      "endOffset" : 173
    }, {
      "referenceID" : 17,
      "context" : "aeruginosa are translocated into competing bacterial cells, resulting in death of the recipients (Hood et al., 2010; Russell et al., 2011).",
      "startOffset" : 97,
      "endOffset" : 138
    }, {
      "referenceID" : 27,
      "context" : "aeruginosa are translocated into competing bacterial cells, resulting in death of the recipients (Hood et al., 2010; Russell et al., 2011).",
      "startOffset" : 97,
      "endOffset" : 138
    }, {
      "referenceID" : 27,
      "context" : "Type six effectors Tse 1 and 3 are hydrolases that degrade the peptidoglycan layer of neighboring bacteria (Russell et al., 2011).",
      "startOffset" : 107,
      "endOffset" : 129
    }, {
      "referenceID" : 17,
      "context" : "aeruginosa has only been observed against other bacteria (Hood et al., 2010).",
      "startOffset" : 57,
      "endOffset" : 76
    }, {
      "referenceID" : 22,
      "context" : "The toxic activity of Tse2 is directed toward the cytoplasmic compartment of targeted bacterial cells (Li et al., 2012), indicating that the toxin has to cross the two membranes of both the attacking and targeted cell.",
      "startOffset" : 102,
      "endOffset" : 119
    }, {
      "referenceID" : 22,
      "context" : "27 Å (Li et al., 2012; Zou et al., 2012), implying that Tsi2 does not undergo any significant conformational changes upon binding to Tse2.",
      "startOffset" : 5,
      "endOffset" : 40
    }, {
      "referenceID" : 20,
      "context" : "To provide additional support for this, we performed a more detailed analysis of the interfaces making up the complex using PISA (Krissinel and Henrick, 2007).",
      "startOffset" : 129,
      "endOffset" : 158
    }, {
      "referenceID" : 22,
      "context" : "mutated Asp-45 and Glu38 in Tsi2, which pair with Arg-119 and Arg-90, respectively, in Tse2, and this abrogated binding of Tsi2 and Tse2 in vitro and eliminated the ability of Tsi2 to detoxify Tse2 in cell-based assays (Li et al., 2012).",
      "startOffset" : 219,
      "endOffset" : 236
    }, {
      "referenceID" : 5,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 10,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 31,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 34,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 36,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 38,
      "context" : "This somewhat sprawling conformation suggests that Tse2 has regions with high flexibility, which is in contrast to the structures other T6SS effectors adopt in compact globular folds (Benz et al., 2012; Dong et al., 2013; Srikannathasan et al., 2013; Wang et al., 2013; Whitney et al., 2013; Zhang et al., 2013).",
      "startOffset" : 183,
      "endOffset" : 311
    }, {
      "referenceID" : 16,
      "context" : "We compared the structure of Tse2 with existing structures in the databases by a Dali structure similarity search (Holm and Sander, 1998).",
      "startOffset" : 114,
      "endOffset" : 137
    }, {
      "referenceID" : 3,
      "context" : "8 Å over 91matchedCa atoms, and 10%amino acid sequence identity (Bell and Eisenberg, 1997).",
      "startOffset" : 64,
      "endOffset" : 90
    }, {
      "referenceID" : 15,
      "context" : "ADPRTs, which transfer ADP-ribose to target molecules thereby inactivating them, are most commonly divided into two groups based on different subsets of catalytic residues: the cholera toxin and the diphtheria toxin groups (Holbourn et al., 2006).",
      "startOffset" : 223,
      "endOffset" : 246
    }, {
      "referenceID" : 18,
      "context" : "5 Å over 69 matched Ca atoms, and 14% amino acid sequence identity) (Jeong et al., 2011).",
      "startOffset" : 68,
      "endOffset" : 88
    }, {
      "referenceID" : 12,
      "context" : "This structural element houses the catalytic machinery of these toxins while the regions surrounding this structural core differ between the toxins, contributing to wide sequence variation among ADPRTs (Fieldhouse and Merrill, 2008).",
      "startOffset" : 202,
      "endOffset" : 232
    }, {
      "referenceID" : 30,
      "context" : "aeruginosa, and evidence indicates that it is likely bound to the interior of the Hcp ring (Silverman et al., 2013).",
      "startOffset" : 91,
      "endOffset" : 115
    }, {
      "referenceID" : 24,
      "context" : "(A) An overlay of Tse2 in green and C3 toxin from Clostridium botulinum is shown with the conserved catalytic residues highlighted (Ménétrey et al., 2002).",
      "startOffset" : 131,
      "endOffset" : 154
    }, {
      "referenceID" : 13,
      "context" : "The alignment includes structures of HopU from Pseudomonas syringae, pertussis toxin from Bordetella pertussis, and exoenzyme C3 from Clostridium limosum (Hazes et al., 1996; Tsuge et al., 2008; Vogelsgesang et al., 2008; Jeong et al., 2011).",
      "startOffset" : 154,
      "endOffset" : 241
    }, {
      "referenceID" : 32,
      "context" : "The alignment includes structures of HopU from Pseudomonas syringae, pertussis toxin from Bordetella pertussis, and exoenzyme C3 from Clostridium limosum (Hazes et al., 1996; Tsuge et al., 2008; Vogelsgesang et al., 2008; Jeong et al., 2011).",
      "startOffset" : 154,
      "endOffset" : 241
    }, {
      "referenceID" : 33,
      "context" : "The alignment includes structures of HopU from Pseudomonas syringae, pertussis toxin from Bordetella pertussis, and exoenzyme C3 from Clostridium limosum (Hazes et al., 1996; Tsuge et al., 2008; Vogelsgesang et al., 2008; Jeong et al., 2011).",
      "startOffset" : 154,
      "endOffset" : 241
    }, {
      "referenceID" : 18,
      "context" : "The alignment includes structures of HopU from Pseudomonas syringae, pertussis toxin from Bordetella pertussis, and exoenzyme C3 from Clostridium limosum (Hazes et al., 1996; Tsuge et al., 2008; Vogelsgesang et al., 2008; Jeong et al., 2011).",
      "startOffset" : 154,
      "endOffset" : 241
    }, {
      "referenceID" : 38,
      "context" : "The heterotetrameric arrangement of the Tse2/Tsi2 toxin-anti-toxin complex is reminiscent of the quaternary structure formed by two other T6SS toxin-anti-toxin pairs (Yang et al., 2014; Zhang et al., 2013).",
      "startOffset" : 166,
      "endOffset" : 205
    }, {
      "referenceID" : 9,
      "context" : "This potential activity, which parallels the cytotoxin effectors of the type III secretion system (Deng and Barbieri, 2008), distinguishes Tse2 from other T6SS effectors and, with an appropriately conserved targetmolecule, would explain the ability of Tse2 to act as a cytotoxin toward both prokaryotic and eukaryotic cells.",
      "startOffset" : 98,
      "endOffset" : 123
    }, {
      "referenceID" : 26,
      "context" : "5 mM IPTG, cells harvested by centrifugation, and chemically lysed (Robb et al., 2012).",
      "startOffset" : 67,
      "endOffset" : 86
    }, {
      "referenceID" : 0,
      "context" : "282 Structure 24, 277–284, February 2, 2016 a2016 Elsevier Ltd All r out in Phenix and resulted in a nearly complete model (Adams et al., 2010).",
      "startOffset" : 123,
      "endOffset" : 143
    }, {
      "referenceID" : 11,
      "context" : "Rounds of restrained refinement in Refmac and manual building in Coot were used to complete the model (Emsley et al., 2010; Murshudov et al., 2011).",
      "startOffset" : 102,
      "endOffset" : 147
    }, {
      "referenceID" : 25,
      "context" : "Rounds of restrained refinement in Refmac and manual building in Coot were used to complete the model (Emsley et al., 2010; Murshudov et al., 2011).",
      "startOffset" : 102,
      "endOffset" : 147
    }, {
      "referenceID" : 7,
      "context" : "Structure validation was carried out using MolProbity, and Ramachandran statistics were taken from this analysis (Chen et al., 2010).",
      "startOffset" : 113,
      "endOffset" : 132
    }, {
      "referenceID" : 23,
      "context" : "Mutagenesis and Toxicity Experiments Mutagenesis of the putative active site was performed as previously described (Liu and Naismith, 2008).",
      "startOffset" : 115,
      "endOffset" : 139
    } ],
    "year" : 2016,
    "abstractText" : null,
    "creator" : "Elsevier"
  }
}